CompletedNot Applicable

Updated Severity and Prognosis Score of Pulmonary Alveolar Proteinosis

China231 participantsStarted 2020-01-01

Plain-language summary

By updating the chest HRCT scoring criteria of patients with pulmonary alveolar proteinosis, a new and more perfect system for evaluating the severity of alveolar proteinosis will be established.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patients had be diagnosed with autoimmune pulmonary alveolar proteinosis through pathology or bronchial alveolar lavage fluid (BALF). * The patients are old than 18 year. * .Every patient had a complete medical history, chest HRCT, pulmonary function and arterial blood gas analysis. * The patients have high level antibody of GM-CSF in serum or BALF. Exclusion Criteria: * The patients had a congenital or secondary pulmonary alveolar proteinosis.

What they're measuring

The severity and prognosis of pulmonary alveolar proteinosis

Timeframe: From July 2020 to December 2021

Trial details

NCT IDNCT04516577

SponsorShanghai Pulmonary Hospital, Shanghai, China

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-31

View on ClinicalTrials.gov More Pulmonary Alveolar Proteinosis trials